This scarcity of cases precludes the delineation of clear genotype-phenotype correlations at the moment; however, risk stratification for cardiac arrhythmia is warranted in patients with KCND3 mutations regardless of the mutation type or location within the gene. This evidence concerns the gene KCND3 and cardiac arrhythmia.